FDA label
What is Byetta used for?
Byetta contains exenatide. The FDA-approved uses below are quoted from the Indications and Usage section of its DailyMed label.
Source: DailyMed SPL label file dated 2026-10-23. Publisher page
The FDA label says: “BYETTA is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.”
Run it in Rivvi
Which 2027 plans near you dropped or restricted Byetta?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Byetta, injection
Indications and Usage, quoted from the label by AstraZeneca Pharmaceuticals LP (NDA021773). Cross-references to other label sections are left out.
BYETTA is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Limitations of Use
- BYETTA contains exenatide. Coadministration with other exenatide-containing products is not recommended.
Source: DailyMed label, set id 53d03c03-ebf7-418d-88a8-533eabd2ee4f, version 26, effective September 2, 2025. NDC 0310-6512, one of 2 listings for this product.
Questions
What is Byetta used for?
The FDA label says: “BYETTA is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.”
What drug class is Byetta?
FDA lists exenatide in the GLP-1 Receptor Agonist established pharmacologic class.
Does this page cover off-label uses or dosing?
No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.